3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 3
1
Status
Completed
2
Unknown
1
Recruiting
1
Not yet recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gynecologic
2
Head & Neck
1
Gastrointestinal
1
Dermatologic
1
Breast
1
Conditions
Breast Neoplasms
14
Neoplasms
7
Endometrial Neoplasms
6
Lung Neoplasms
5
Melanoma
4
Head and Neck Neoplasms
4
Colonic Neoplasms
4
Esophageal Neoplasms
3
Uterine Cervical Neoplasms
2
Solitary Pulmonary Nodule
2
Multiple Pulmonary Nodules
2
Lymphedema
2
Colorectal Neoplasms
2
Carcinoma, Hepatocellular
2
Brain Neoplasms
2
Vulvar Neoplasms
1
Uterine Neoplasms
1
Thyroid Neoplasms
1
Suspected Central Nervous System Tumors
1
Stomach Neoplasms
1
Skull Base Neoplasms
1
Skin Neoplasms
1
Sarcoma, Ewing
1
Sarcoma
1
Rhabdomyosarcoma
1
Recurrence
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Peritoneal Neoplasms
1
Pediatric Patients With Solid Tumors
1
Interventions
Cisplatin
72
Brachytherapy
31
Radiotherapy
26
Paclitaxel
23
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
21
human papillomavirus vaccine, L1 type 16, 18
20
Topotecan
18
Papillomavirus Vaccines
18
Carboplatin
18
Surveys and Questionnaires
17
Bevacizumab
16
pembrolizumab
14
Radiation
12
Gemcitabine
12
Early Intervention, Educational
12
Colposcopy
12
Methods
11
Magnetic Resonance Spectroscopy
11
atezolizumab
10
Radiotherapy, Intensity-Modulated
10
Blood Specimen Collection
10
Papanicolaou Test
9
Docetaxel
9
Vaccines, Synthetic
8
Platinum
8
Nivolumab
8
Ipilimumab
8
Counseling
8
1,2-diaminocyclohexaneplatinum II citrate
8
Vaccines
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Completed
×
Uterine Cervical Neoplasms
×
Indocyanine Green
×
Clear all
NCT02997553
2023-01-09
GASVERT
Institut de Cancérologie de Lorraine
Phase 3
Completed
744 enrolled
NCT01673022
2018-07-24
FIRES
Indiana University
Phase NA
Completed
430 enrolled
7 charts